000 | 01938 a2200613 4500 | ||
---|---|---|---|
005 | 20250518085754.0 | ||
264 | 0 | _c20210119 | |
008 | 202101s 0 0 eng d | ||
022 | _a1462-0332 | ||
024 | 7 |
_a10.1093/rheumatology/kez669 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLiu, Yanying | |
245 | 0 | 0 |
_aRelapse predictors and serologically unstable condition of IgG4-related disease: a large Chinese cohort. _h[electronic resource] |
260 |
_bRheumatology (Oxford, England) _c08 2020 |
||
300 |
_a2115-2123 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAzathioprine _xtherapeutic use |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGlucocorticoids _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin G _xblood |
650 | 0 | 4 |
_aImmunoglobulin G4-Related Disease _xblood |
650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aMycophenolic Acid _xtherapeutic use |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aZeng, Qiaozhu | |
700 | 1 | _aZhu, Lijuan | |
700 | 1 | _aGao, Jingyuan | |
700 | 1 | _aWang, Ziqiao | |
700 | 1 | _aWang, Zhenfan | |
700 | 1 | _aYang, Fei | |
700 | 1 | _aWang, Kunkun | |
700 | 1 | _aChen, Da | |
700 | 1 | _aXia, Changsheng | |
700 | 1 | _aZhang, Shanshan | |
700 | 1 | _aWang, Yi | |
700 | 1 | _aShen, Danhua | |
700 | 1 | _aYu, Guangyan | |
700 | 1 | _aLi, Zhan-Guo | |
773 | 0 |
_tRheumatology (Oxford, England) _gvol. 59 _gno. 8 _gp. 2115-2123 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1093/rheumatology/kez669 _zAvailable from publisher's website |
999 |
_c30672206 _d30672206 |